# Pacer BioThreat Strategy ETF (VIRS): ETF Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/virs for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: Pacer · Asset class: Equity - Strategy: — · Inception: 2020-06-29 The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. The Advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. It is non-diversified. ## Key Facts | Metric | Value | |---|---| | Price | $40.03 | | Expense Ratio | 0.70% | | Assets Under Management | $3.7M | | NAV | $37.15 | | Holdings Count | 56 | | Distribution Yield (TTM) | — | | Annual Distribution (TTM) | — /share | | Distribution Frequency | Quarterly | | 52-Week Range | $30.30 – $40.03 | | Beta | 0.92 | ## Latest Distribution - Amount: $0.0723 /share - Ex-date: 2024-09-26 - Pay date: 2024-10-02 ## Frequently Asked Questions ### What does VIRS invest in? The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. The Advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. It is non-diversified. ### What is the expense ratio of VIRS? Pacer BioThreat Strategy ETF (VIRS) charges an expense ratio of 0.70%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is VIRS? Pacer BioThreat Strategy ETF (VIRS) manages $3.7M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is VIRS actively managed or an index fund? VIRS's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy. ### When was VIRS launched? Pacer BioThreat Strategy ETF (VIRS) launched in June 2020 and is managed by Pacer. ### How has VIRS performed? VIRS's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does VIRS pay a dividend? Pacer BioThreat Strategy ETF (VIRS) currently distributes little or no income. Trailing-twelve-month yield is —. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does VIRS pay dividends? Pacer BioThreat Strategy ETF pays dividends Quarterly. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is VIRS's dividend yield? VIRS's trailing-twelve-month yield is —, calculated from the sum of dividends over the past year divided by the current price. ### When is VIRS's next ex-dividend date? The most recently announced ex-dividend date for VIRS was 2024-09-26. The next ex-date typically follows Quarterly; once announced it appears at the top of the dividend history table on this page. ### How much will VIRS's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 0.70% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does VIRS charge its expense ratio? The expense ratio is deducted in tiny daily slices from VIRS's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does VIRS cost more than a fund like VOO? VIRS's strategy (current expense ratio 0.70%) is different from a broad-market index tracker like VOO, so its fee belongs to a different cohort. The Cost Verdict card above shows you where VIRS sits within its own category, which is the comparison that actually matters. ### Are there cheaper alternatives to VIRS? The Lower-Fee Alternatives card above lists ETFs following the same investment strategy as VIRS (0.70%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/virs - Distribution history: https://www.dividenddata.com/funds/virs/dividend - Holdings & diversification: https://www.dividenddata.com/funds/virs/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/virs/expenses - Peer comparison: https://www.dividenddata.com/funds/virs/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.